Astellas Pharma | 4503 - Operating Profit


Astellas Pharma reported JPY132.59B in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Astellas Pharma JPY 132.59B 52.76B Sep/2026
Chugai Pharma JPY 202.95B 42.09B Sep/2026
Daiichi Sankyo JPY 108.7B 23.6B Sep/2026
Eisai JPY 16.7B 8.03B Sep/2026
Kyowa Hakko Kirin JPY 26.41B 4.15B Sep/2026
M3 JPY 17.84B 1.29B Sep/2026
Otsuka Holdings JPY 142.24B 1.83B Sep/2026
Shionogi JPY 48.33B 18.58B Sep/2026
Sumitomo Dainippon JPY 23.29B 5.54B Sep/2026
Takeda JPY 205.32B 3.9B Sep/2026
Terumo JPY 89.48B 58.03B Jun/2026